دورية أكاديمية

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.

التفاصيل البيبلوغرافية
العنوان: Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
المؤلفون: Tan, Daniel S.W., Felip, Enriqueta, de Castro, Gilberto, Solomon, Benjamin J., Greystoke, Alastair, Cho, Byoung Chul, Cobo, Manuel, Kim, Tae Min, Ganguly, Sandip, Carcereny, Enric, Paz-Ares, Luis, Bennouna, Jaafar, Garassino, Marina Chiara, Schenker, Michael, Kim, Sang-We, Brase, Jan C., Bury-Maynard, Denise, Passos, Vanessa Q., Deudon, Stéphanie, Dharan, Bharani
المصدر: Journal of Clinical Oncology; 1/10/2024, Vol. 42 Issue 2, p192-204, 15p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.23.00980